NEW YORK (GenomeWeb News) – MDS today announced that it expects to report 2008 revenue growth of between 12 percent and 16 percent.
 
The Toronto-based firm said its revenues for full-year 2008 should be between $1.35 billion and $1.4 billion, up from $1.2 billion in 2007.
 
MDS also said it expects to report adjusted EBITDA in the range of $175 million to $185 million and adjusted earnings per share of $.37 to $.43, compared with adjusted EBITDA of $145 million, or $.34 per share, in 2007.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.